T lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis
- PMID: 1596021
- DOI: 10.1164/ajrccm/145.6.1477
T lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis
Abstract
With the use of monoclonal antibodies (mAb) and immunohistology, the numbers of phenotypically distinct cells infiltrating lung tissue from 15 postmortem (PM) cases of fatal asthma were quantified and compared with 6 cases of cystic fibrosis (CF) (three postmortem, three transplant) and 10 nonasthmatic cases of sudden death matched for age and sex. Tissue eosinophilia was significantly greater (p less than 0.001) in the fatal asthma group than in the CF or sudden death controls. In asthma, approximately 40% of the eosinophilic infiltrate was EG2 positive (an indication of eosinophil activation and secretion of eosinophil cationic protein). The numbers of eosinophils and EG2 positive cells were significantly elevated in the subjects with acute severe asthma who had had a duration of terminal illness exceeding, as compared with less than, 24 h (p less than 0.05). When compared with the sudden death controls, there were increases in the numbers of Dako L C positive cells (i.e., CD45 positive "total leukocytes") in both fatal asthma and CF (p less than 0.01 and 0.05, respectively). The mean number of MT-1 positive (T) cells in the asthma and CF groups was approximately twice that of the control (p less than 0.05 and 0.01, respectively). The mean number of MB2 positive (B) cells was similar for both the asthma and sudden death control groups but was significantly increased in CF (p less than 0.05). The average T:B cell ratios were 6:1, 1:1, and 2:1 in the fatal asthma, CF, and control groups, respectively. The results support a role for the T lymphocyte in the pathogenesis of fatal asthma and CF.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Relationship to symptoms and bronchial responsiveness.Am Rev Respir Dis. 1992 Aug;146(2):500-6. doi: 10.1164/ajrccm/146.2.500. Am Rev Respir Dis. 1992. PMID: 1489147
-
Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma.Am Rev Respir Dis. 1990 Dec;142(6 Pt 1):1407-13. doi: 10.1164/ajrccm/142.6_Pt_1.1407. Am Rev Respir Dis. 1990. PMID: 2252260
-
Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa?Am Rev Respir Dis. 1993 Sep;148(3):713-9. doi: 10.1164/ajrccm/148.3.713. Am Rev Respir Dis. 1993. PMID: 8368644
-
Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa.Am J Respir Crit Care Med. 1996 Feb;153(2):551-6. doi: 10.1164/ajrccm.153.2.8564096. Am J Respir Crit Care Med. 1996. PMID: 8564096 Clinical Trial.
-
[Eosinophil activation evaluated by using a anti-human secreted form of ECP antibody (EG2)].Nihon Rinsho. 1993 Mar;51(3):626-30. Nihon Rinsho. 1993. PMID: 8492435 Review. Japanese.
Cited by
-
Differential effect of phosphodiesterase 4 inhibitors on the proliferation of human peripheral blood mononuclear cells from normals and subjects with atopic dermatitis.Br J Pharmacol. 1995 Dec;116(8):3169-74. doi: 10.1111/j.1476-5381.1995.tb15120.x. Br J Pharmacol. 1995. PMID: 8719792 Free PMC article.
-
Recommendation for optimal management of severe refractory asthma.J Asthma Allergy. 2010 Jul 26;3:43-56. doi: 10.2147/jaa.s6710. J Asthma Allergy. 2010. PMID: 21437039 Free PMC article.
-
Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity.J Exp Med. 1996 Jan 1;183(1):109-17. doi: 10.1084/jem.183.1.109. J Exp Med. 1996. PMID: 8551213 Free PMC article.
-
Ouabain attenuates ovalbumin-induced airway inflammation.Inflamm Res. 2017 Dec;66(12):1117-1130. doi: 10.1007/s00011-017-1092-9. Epub 2017 Sep 13. Inflamm Res. 2017. PMID: 28905075
-
Monoclonal antibodies for the treatment of severe asthma.Curr Allergy Asthma Rep. 2011 Jun;11(3):253-60. doi: 10.1007/s11882-011-0184-9. Curr Allergy Asthma Rep. 2011. PMID: 21360131 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous